Ciarán E Fealy1,2, Stephan Nieuwoudt1,3, Julie A Foucher1, Amanda R Scelsi1, Steven K Malin1, Mangesh Pagadala1,4, Lauren A Cruz1, Miranda Li1, Michael Rocco5, Bartolome Burguera6, John P Kirwan1,3. 1. Department of Pathobiology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA. 2. Department of Biomedical Sciences, Kent State University, Kent, OH, USA. 3. Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA. 4. Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA. 5. Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA. 6. Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract
NEW FINDINGS: What is the central question of this study? Does short-duration, high-intensity exercise training that combines functional aerobic and resistance exercises into training sessions lasting 8-20 min benefit individuals with type 2 diabetes? What is the main finding and its importance? Functional high-intensity training improves insulin sensitivity and reduces cardiometabolic risk in individuals with type 2 diabetes. This type of exercise training may be an effective exercise mode for managing type 2 diabetes. The increase in insulin sensitivity addresses a key defect in type 2 diabetes. ABSTRACT: Functional high-intensity training (F-HIT) is a novel fitness paradigm that integrates simultaneous aerobic and resistance training in sets of constantly varied movements, based on real-world situational exercises, performed at high-intensity in workouts that range from ∼8 to 20 min per session. We hypothesized that F-HIT would be an effective exercise mode for reducing insulin resistance in type 2 diabetes (T2D). We recruited 13 overweight/obese adults (5 males, 8 females; 53 ± 7 years; BMI 34.5 ± 3.6 kg m-2 , means ± SD) with T2D to participate in a 6-week (3 days week-1 ) supervised F-HIT programme. An oral glucose tolerance test was used to derive measures of insulin sensitivity. F-HIT significantly reduced fat mass (43.8 ± 83.8 vs. 41.6 ± 7.9 kg; P < 0.01), diastolic blood pressure (80.2 ± 7.1 vs. 74.5 ± 5.8; P < 0.01), blood lipids (triglyceride and VLDL, both P < 0.05) and metabolic syndrome z-score (6.4 ± 4.5 vs. -0.2 ± 5.2 AU; P < 0.001), and increased basal fat oxidation (0.08 ± 0.03 vs. 0.10 ± 0.04 g min-1 ; P = 0.05), and high molecular mass adiponectin (214.4 ± 88.9 vs. 288.8 ± 127.4 ng mL-1 ; P < 0.01). Importantly, F-HIT also increased insulin sensitivity (0.037 ± 0.010 vs. 0.042 ± 0.010 AU; P < 0.05). Increases in high molecular mass adiponectin and basal fat oxidation correlated with the change in insulin sensitivity (ρ, 0.75, P < 0.05 and ρ, 0.81, P < 0.01, respectively). Compliance with the training programme was >95% and no injuries or adverse events were reported. These data suggest that F-HIT may be an effective exercise mode for managing T2D. The increase in insulin sensitivity addresses a key defect in T2D and is consistent with improvements observed after more traditional aerobic exercise programmes in overweight/obese adults with T2D.
NEW FINDINGS: What is the central question of this study? Does short-duration, high-intensity exercise training that combines functional aerobic and resistance exercises into training sessions lasting 8-20 min benefit individuals with type 2 diabetes? What is the main finding and its importance? Functional high-intensity training improves insulin sensitivity and reduces cardiometabolic risk in individuals with type 2 diabetes. This type of exercise training may be an effective exercise mode for managing type 2 diabetes. The increase in insulin sensitivity addresses a key defect in type 2 diabetes. ABSTRACT: Functional high-intensity training (F-HIT) is a novel fitness paradigm that integrates simultaneous aerobic and resistance training in sets of constantly varied movements, based on real-world situational exercises, performed at high-intensity in workouts that range from ∼8 to 20 min per session. We hypothesized that F-HIT would be an effective exercise mode for reducing insulin resistance in type 2 diabetes (T2D). We recruited 13 overweight/obese adults (5 males, 8 females; 53 ± 7 years; BMI 34.5 ± 3.6 kg m-2 , means ± SD) with T2D to participate in a 6-week (3 days week-1 ) supervised F-HIT programme. An oral glucose tolerance test was used to derive measures of insulin sensitivity. F-HIT significantly reduced fat mass (43.8 ± 83.8 vs. 41.6 ± 7.9 kg; P < 0.01), diastolic blood pressure (80.2 ± 7.1 vs. 74.5 ± 5.8; P < 0.01), blood lipids (triglyceride and VLDL, both P < 0.05) and metabolic syndrome z-score (6.4 ± 4.5 vs. -0.2 ± 5.2 AU; P < 0.001), and increased basal fat oxidation (0.08 ± 0.03 vs. 0.10 ± 0.04 g min-1 ; P = 0.05), and high molecular mass adiponectin (214.4 ± 88.9 vs. 288.8 ± 127.4 ng mL-1 ; P < 0.01). Importantly, F-HIT also increased insulin sensitivity (0.037 ± 0.010 vs. 0.042 ± 0.010 AU; P < 0.05). Increases in high molecular mass adiponectin and basal fat oxidation correlated with the change in insulin sensitivity (ρ, 0.75, P < 0.05 and ρ, 0.81, P < 0.01, respectively). Compliance with the training programme was >95% and no injuries or adverse events were reported. These data suggest that F-HIT may be an effective exercise mode for managing T2D. The increase in insulin sensitivity addresses a key defect in T2D and is consistent with improvements observed after more traditional aerobic exercise programmes in overweight/obese adults with T2D.
Authors: Bonnie J Brehm; Suzanne E Spang; Barbara L Lattin; Randy J Seeley; Stephen R Daniels; David A D'Alessio Journal: J Clin Endocrinol Metab Date: 2004-12-14 Impact factor: 5.958
Authors: D Hansen; P Dendale; R A M Jonkers; M Beelen; R J F Manders; L Corluy; A Mullens; J Berger; R Meeusen; L J C van Loon Journal: Diabetologia Date: 2009-04-16 Impact factor: 10.122
Authors: Thomas Pj Solomon; Jacob M Haus; Karen R Kelly; Marc D Cook; Julianne Filion; Michael Rocco; Sangeeta R Kashyap; Richard M Watanabe; Hope Barkoukis; John P Kirwan Journal: Am J Clin Nutr Date: 2010-10-27 Impact factor: 7.045
Authors: John P Kirwan; Thomas P J Solomon; Daniel M Wojta; Myrlene A Staten; John O Holloszy Journal: Am J Physiol Endocrinol Metab Date: 2009-04-21 Impact factor: 4.310
Authors: L M Fenicchia; J A Kanaley; J L Azevedo; C S Miller; R S Weinstock; R L Carhart; L L Ploutz-Snyder Journal: Metabolism Date: 2004-03 Impact factor: 8.694
Authors: Magni Mohr; Nikolai Baastrup Nordsborg; Annika Lindenskov; Hildigunn Steinholm; Hans Petur Nielsen; Jann Mortensen; Pal Weihe; Peter Krustrup Journal: Biomed Res Int Date: 2014-04-10 Impact factor: 3.411
Authors: Verena Menz; Natalie Marterer; Sachin B Amin; Martin Faulhaber; Alexander B Hansen; Justin S Lawley Journal: J Sports Sci Med Date: 2019-08-01 Impact factor: 2.988
Authors: Maria Rosaria Squeo; Barbara Di Giacinto; Marco Alfonso Perrone; Massimo Santini; Maria Luisa Sette; Emanuele Fabrizi; Antonia Vaquer; Attilio Parisi; Antonio Spataro; Alessandro Biffi Journal: J Cardiovasc Dev Dis Date: 2022-06-06
Authors: Sultan Ayoub Meo; Abdulelah Adnan Abukhalaf; Ali Abdullah Alomar; Omar Mohammed Alessa; Omar Yassin Sumaya; Anusha Sultan Meo Journal: Int J Environ Res Public Health Date: 2021-02-11 Impact factor: 3.390
Authors: Sultan Ayoub Meo; Abdulelah Adnan Abukhalaf; Ali Abdullah Alomar; Waqas Sami; Anusha Sultan Meo Journal: Pak J Med Sci Date: 2021 Jul-Aug Impact factor: 1.088